U.S. Markets
Ligand Pharmaceuticals (LGND) to acquire Xoma Royalty (XOMA) for c. USD 740mln, WSJ reports citing sources
Related stocks
2 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
